Clinical Trial Update: hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating hMG versus recombinant FSH for prevention of ovarian hyperstimulation syndrome in women with polycystic ovary syndrome undergo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• hMG (human menopausal gonadotropin)
• recombinant FSH (follicle-stimulating hormone)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED